Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tuberculosis"" wg kryterium: Temat


Tytuł:
The impact of pulmonary tuberculosis on immunological and metabolic features of diabetic patients.
Autorzy:
Chen H; Department of Computed Tomography, Heilongjiang Provincial Hospital, Harbin, China.
Su L; Neuroscience Research Institute, Peking University Center of Medical and Health Analysis, Peking University, Beijing, China.
Bao J; College of Sports and Human Sciences, Harbin Sport University, Harbin, China.
Zhang K; Department of Clinical Nutrition, Heilongjiang Provincial Hospital, Harbin, China.
Li Y; Department of Clinical Nutrition, Heilongjiang Provincial Hospital, Harbin, China.; Department of the Fourth Internal Medicine, The Fourth Hospital of Heilongjiang Province, Harbin, China.
Mao E; Department of Discipline Inspection and Supervision, Heilongjiang Provincial Hospital, Harbin, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Aug 23; Vol. 13, pp. 973991. Date of Electronic Publication: 2022 Aug 23 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2*/immunology
Diabetes Mellitus, Type 2*/metabolism
Tuberculosis, Pulmonary*/complications
Humans ; Interleukin-10 ; Latent Tuberculosis ; Tuberculosis
Czasopismo naukowe
Tytuł:
Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2.
Autorzy:
Asadian M; Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hassanzadeh SM; BCG Vaccine Production Plant, Pasteur Institute of Iran, Karaj, Iran.
Safarchi A; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Douraghi M; Division of Microbiology, Department of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2022 Aug 21; Vol. 23 (1), pp. 609. Date of Electronic Publication: 2022 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
BCG Vaccine*/genetics
Mycobacterium bovis*/genetics
Mycobacterium bovis*/immunology
Mycobacterium tuberculosis*/genetics
Mycobacterium tuberculosis*/immunology
Epitopes, T-Lymphocyte/genetics ; Genomics ; Humans ; Tuberculosis/microbiology ; Tuberculosis/prevention & control ; Tuberculosis Vaccines/genetics
Czasopismo naukowe
Tytuł:
Novel rrs mutations in second-line injectable drug-resistant clinical isolates of Mycobacterium tuberculosis from the Punjab province of Pakistan.
Autorzy:
Sarwer MI; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: .
Khan MT; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: .
Khurshid S; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore. 1KM Defense Road, Lahore, 58810, Pakistan. Electronic address: sanakhurshid_.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2022 Aug; Vol. 28 (8), pp. 1119-1124. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Multiple, Bacterial*/genetics
Mycobacterium tuberculosis*/genetics
Mycobacterium tuberculosis*/isolation & purification
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/genetics
Antitubercular Agents/adverse effects ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Genes, Bacterial/genetics ; Humans ; Microbial Sensitivity Tests ; Mutation ; Pakistan ; Rifampin/pharmacology ; Rifampin/therapeutic use ; Tuberculosis, Lymph Node
Czasopismo naukowe
Tytuł:
Assessing the utility of the Xpert Mycobacterium tuberculosis/rifampin assay for analysis of bronchoalveolar lavage fluid in patients with suspected pulmonary tuberculosis.
Autorzy:
Bai W; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Liu L; Department of Clinical Laboratory Medicine, Wenzhou Longwan First People's Hospital, Wenzhou, China.
Wu L; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Chen S; Department of Blood Transfusion, People's Hospital of Pingyang County, Wenzhou, China.
Wu S; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Wang Z; Department of Obstetrics and Gynecology, Wenzhou Central Hospital, Wenzhou, China.
Xu K; Department of Clinical Laboratory Medicine, Wenzhou Central Hospital, Wenzhou, China.
Chi Q; Department of Respiratory and Critical Care Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Pan Y; Department of Clinical Laboratory Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Xu X; Department of Clinical Laboratory Medicine, Key Laboratory of precision medicine of Wenzhou, Wenzhou Central Hospital, Wenzhou, China.
Pokaż więcej
Źródło:
Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Jan; Vol. 36 (1), pp. e24154. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/genetics
Drug Resistance, Multiple, Bacterial/*genetics
Molecular Typing/*methods
Tuberculosis, Pulmonary/*diagnosis
Adult ; Antibiotics, Antitubercular/pharmacology ; Bronchoalveolar Lavage Fluid/microbiology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Rifampin/pharmacology ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/microbiology ; Tuberculosis, Pulmonary/microbiology
Czasopismo naukowe
Tytuł:
Long non-coding RNA SNHG16 silencing inhibits proliferation and inflammation in Mycobacterium tuberculosis-infected macrophages by targeting miR-140-5p expression.
Autorzy:
Sun W; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Zhang X; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
He X; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Zhang J; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Wang X; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Lin W; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Wang X; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China.
Wu X; Senior Department of Tuberculosis, The 8th Medical Center of Chinese People's Liberation Army General Hospital, Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Beijing 100091, China. Electronic address: .
Pokaż więcej
Źródło:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2022 Sep; Vol. 103, pp. 105325. Date of Electronic Publication: 2022 Jun 29.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
RNA, Long Noncoding*/genetics
Tuberculosis*/diagnosis
Tuberculosis*/genetics
Biomarkers ; Cell Proliferation/genetics ; Humans ; Inflammation/metabolism ; Macrophages/metabolism ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Toll-like receptor-mediated innate immune responses by recognition of the recombinant dormancy-associated Mycobacterium tuberculosis proteins Rv2659c and Rv1738.
Autorzy:
Saelee C; Faculty of Medical Technology, Department of Clinical Microbiology and Applied Technology, Mahidol University, Bangkok, Thailand.
Hanthamrongwit J; Faculty of Medical Technology, Department of Clinical Microbiology and Applied Technology, Mahidol University, Bangkok, Thailand.
Soe PT; Faculty of Medical Technology, Department of Clinical Microbiology and Applied Technology, Mahidol University, Bangkok, Thailand.; Department of Medical Laboratory Technology, University of Medical Technology, Mandalay, Myanmar.
Khaenam P; Faculty of Medical Technology, Center of Standardization and Product Validation, Mahidol University, Bangkok, Thailand.
Inthasin N; Faculty of Medicine Siriraj Hospital, Department of Immunology, Mahidol University, Bangkok, Thailand.
Ekpo P; Faculty of Medicine Siriraj Hospital, Department of Immunology, Mahidol University, Bangkok, Thailand.
Chootong P; Faculty of Medical Technology, Department of Clinical Microbiology and Applied Technology, Mahidol University, Bangkok, Thailand.
Leepiyasakulchai C; Faculty of Medical Technology, Department of Clinical Microbiology and Applied Technology, Mahidol University, Bangkok, Thailand.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Sep 01; Vol. 17 (9), pp. e0273517. Date of Electronic Publication: 2022 Sep 01 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacterial Proteins*/genetics
Bacterial Proteins*/immunology
Immunity, Innate*/genetics
Mycobacterium tuberculosis*/immunology
Toll-Like Receptors*/genetics
Tuberculosis*/genetics
Cytokines/metabolism ; Humans ; Leukocytes, Mononuclear/metabolism ; Recombinant Proteins/genetics ; Toll-Like Receptor 2/metabolism ; Toll-Like Receptor 4/genetics ; Tuberculosis Vaccines
Czasopismo naukowe
Tytuł:
Estimation of tuberculosis incidence at subnational level using three methods to monitor progress towards ending TB in India, 2015-2020.
Autorzy:
Jeyashree K; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Thangaraj J; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Rade K; World Health Organization, Country Office for India, New Delhi, India.
Modi B; GMERS Medical College & Civil Hospital, Gandhinagar, Gujarat, India.
Selvaraju S; ICMR - National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Velusamy S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Akhil S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Vijayageetha M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Sudha Rani D; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Sabarinathan R; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Manikandanesan S; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Elumalai R; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Natarajan M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Joseph B; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India.
Mahapatra A; ICMR-Regional Medical Research Centre, Bhubaneswar, Orissa, India.
Shamim A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shah A; USAID India Mission, New Delhi, Delhi, India.
Bhardwaj A; MM Medical College & Hospital, Kumarhatti, Solan, Himachal Pradesh, India.
Purty A; Pondicherry Institute of Medical Sciences, Puducherry, India.
Vadera B; Wadhwani Institute of Artificial Intelligence, Mumbai, India.
Sridhar A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Chowdhury A; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shafie A; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Choudhury A; World Health Organization, Country Office for India, New Delhi, India.
Dhrubjyoti D; WHO-NTEP Technical Assistance Project, New Delhi, India.
Solanki H; WHO-NTEP Technical Assistance Project, New Delhi, India.
Sirmanwar K; PATH India, New Delhi, India.
Khaparde K; WHO-NTEP Technical Assistance Project, New Delhi, India.
Parmar M; World Health Organization, Country Office for India, New Delhi, India.
Dahiya N; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Debdutta P; WHO-NTEP Technical Assistance Project, New Delhi, India.
Ahmed Q; CDC, New Delhi, Delhi, India.
Ramachandran R; World Health Organization, Country Office for India, New Delhi, India.
Prasad R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Shinde R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Baruah R; Gauhati Medical College, Guwahati, Assam, India.
Chauhan S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Bharaswadkar S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Achanta S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Sharath BN; ESIC Medical College and PGIMSR, Bengaluru-560010, Karnataka, India.
Balakrishnan S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Chandra S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Khumukcham S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Mandal S; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Chalil S; WHO-NTEP Technical Assistance Project, New Delhi, India.
Shah V; WHO-NTEP Technical Assistance Project, New Delhi, India.
Roddawar V; PATH India, New Delhi, India.
Rao R; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Sachdeva K; Central TB Division, Ministry of Health & Family Welfare, New Delhi, Delhi, India.
Murhekar M; ICMR- National Institute of Epidemiology, Chennai, Tamil Nadu, India .
Pokaż więcej
Corporate Authors:
Subnational TB claims verification group
Źródło:
BMJ open [BMJ Open] 2022 Jul 28; Vol. 12 (7), pp. e060197. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epidemiological Monitoring*
Tuberculosis*/diagnosis
Tuberculosis*/epidemiology
Tuberculosis*/prevention & control
Disease Eradication ; Humans ; Incidence ; India/epidemiology ; Mycobacterium tuberculosis/isolation & purification
Czasopismo naukowe
Tytuł:
Hit Compounds and Associated Targets in Intracellular Mycobacterium tuberculosis .
Autorzy:
Tsui CKM; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore 308442, Singapore.
Sorrentino F; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Narula G; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Mendoza-Losana A; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.; Department of Bioengineering and Aerospace Engineering, Carlos III University of Madrid, 28040 Madrid, Spain.
Del Rio RG; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Herrán EP; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Lopez A; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Bojang A; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Zheng X; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Remuiñán-Blanco MJ; GSK, Global Health Medicines R&D, PTM, Tres Cantos, 28760 Madrid, Spain.
Av-Gay Y; Department of Medicine and Microbiology and Immunology, Life Science Institute, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2022 Jul 12; Vol. 27 (14). Date of Electronic Publication: 2022 Jul 12.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/pharmacology
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/genetics
Bacterial Proteins/genetics ; Humans ; INDEL Mutation ; Macrophages/microbiology ; Microbial Sensitivity Tests ; Mutation ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
High-Dose Mycobacterium tuberculosis H37rv Infection in IL-17A- and IL-17A/F-Deficient Mice.
Autorzy:
Ritter K; Infection Immunology, Research Center Borstel, D-23845 Borstel, Germany.
Behrends J; Fluorescence Cytometry Core Unit, Research Center Borstel, D-23845 Borstel, Germany.
Rückerl D; Lydia Becker Institute of Immunology and Inflammation, School of Biological Sciences, University of Manchester, Manchester M13 9PL, UK.
Hölscher A; Infection Immunology, Research Center Borstel, D-23845 Borstel, Germany.
Volz J; Infection Immunology, Research Center Borstel, D-23845 Borstel, Germany.
Prinz I; Center for Molecular Neurobiology Hamburg, Eppendorf University Medical Center, D-20246 Hamburg, Germany.
Hölscher C; Infection Immunology, Research Center Borstel, D-23845 Borstel, Germany.; Thematic Translational Unit Tuberculosis, German Center for Infection Research (DZIF), D-38124 Braunschweig, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2022 Sep 14; Vol. 11 (18). Date of Electronic Publication: 2022 Sep 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Interleukin-17*/deficiency
Interleukin-17*/metabolism
Tuberculosis*/immunology
Animals ; Cytokines/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mycobacterium tuberculosis/metabolism
Czasopismo naukowe
Tytuł:
A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis.
Autorzy:
Berton S; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Chen L; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Liang YC; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Xu Z; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
Afriyie-Asante A; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Rajabalee N; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
Yang W; Chinese Academy of Sciences Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. Electronic address: .
Sun J; Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada; Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1H 8M5, Canada. Electronic address: .
Pokaż więcej
Źródło:
Cell chemical biology [Cell Chem Biol] 2022 Jul 21; Vol. 29 (7), pp. 1126-1139.e12. Date of Electronic Publication: 2022 Mar 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Autophagy*
Protein Phosphatase 2C*/antagonists & inhibitors
Tuberculosis*/drug therapy
Animals ; Macrophages/metabolism ; Macrophages/microbiology ; Mice ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Expression of mycobacterium tuberculosis induced SOCS3 and STAT3 and the implications on innate immunity in TB patients vs healthy contacts in high TB/HIV endemic setting: A cross-sectional analytical study.
Autorzy:
Lungu P; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.
Mushota K; USAID Sustaining Technical and Analytic Resources (STAR) Project, Lusaka, Zambia.
Njelesani E; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Sukwa T; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Lakhi S; Department of Internal Medicine, University of Zambia School of Medicine, Lusaka, Zambia.
Mwaba P; Faculty of Medicine, Lusaka Apex Medical University, Lusaka, Zambia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jul 15; Vol. 17 (7), pp. e0263624. Date of Electronic Publication: 2022 Jul 15 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
HIV Infections*/complications
Immunity, Innate*/genetics
STAT3 Transcription Factor*/genetics
STAT3 Transcription Factor*/metabolism
Suppressor of Cytokine Signaling 3 Protein*/genetics
Suppressor of Cytokine Signaling 3 Protein*/metabolism
Tuberculosis*/genetics
Tuberculosis*/immunology
Cross-Sectional Studies ; Humans ; Interleukin-6/metabolism ; Mycobacterium tuberculosis/immunology ; Signal Transduction ; Suppressor of Cytokine Signaling Proteins/genetics ; Suppressor of Cytokine Signaling Proteins/metabolism ; Zambia/epidemiology
Czasopismo naukowe
Tytuł:
MicroRNA-20b carried by mesenchymal stem cell-derived extracellular vesicles protects alveolar epithelial type II cells from Mycobacterium tuberculosis infection in vitro.
Autorzy:
Yan K; Department of Respiratory Nursing, Qingdao Central Hospital, Qingdao 266034, Shandong, PR China.
Xu G; Department of Respiratory Nursing, Qingdao Central Hospital, Qingdao 266034, Shandong, PR China.
Li Z; Department of Respiratory Medicine, Linyi High-tech Zone People's Hospital, Linyi 276200, Shandong, PR China. Electronic address: Mr_.
Pokaż więcej
Źródło:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2022 Jul; Vol. 101, pp. 105292. Date of Electronic Publication: 2022 Apr 30.
Typ publikacji:
Journal Article
MeSH Terms:
Extracellular Vesicles*/genetics
Mesenchymal Stem Cells*/microbiology
MicroRNAs*/genetics
Tuberculosis*/prevention & control
A549 Cells ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Synthesis, molecular docking, and biological evaluation of novel 1,2,4-triazole-isatin derivatives as potential Mycobacterium tuberculosis shikimate kinase inhibitors.
Autorzy:
Dadlani VG; Department of Pharmaceutical Chemistry, Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar, India.
Chhabhaiya H; Department of Pharmaceutical Chemistry, Dr. L. H. Hiranandani College of Pharmacy, Ulhasnagar, India.
Somani RR; Department of Pharmaceutical Chemistry, D Y Patil University School of Pharmacy, Navi Mumbai, India.
Tripathi PK; Institute of Pharmaceutical Sciences, University of Lucknow, Lucknow, India.
Pokaż więcej
Źródło:
Chemical biology & drug design [Chem Biol Drug Des] 2022 Aug; Vol. 100 (2), pp. 230-244. Date of Electronic Publication: 2022 Jun 06.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/chemistry
Antitubercular Agents*/pharmacology
Isatin*/chemistry
Isatin*/pharmacology
Mycobacterium tuberculosis*/drug effects
Phosphotransferases (Alcohol Group Acceptor)*/antagonists & inhibitors
Triazoles*/chemistry
Triazoles*/pharmacology
HEK293 Cells ; Humans ; Microbial Sensitivity Tests ; Molecular Docking Simulation ; Shikimic Acid ; Structure-Activity Relationship ; Tuberculosis/drug therapy
Czasopismo naukowe
Tytuł:
Imaging characteristics of pulmonary BCG/TB infection in patients with chronic granulomatous disease.
Autorzy:
Yao Q; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Zhou QH; Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Shen QL; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Wang XC; Department of Allergy and Clinical Immunology, Children's Hospital of Fudan University, Shanghai, 201102, China.
Hu XH; Department of Radiology, Children's Hospital of Fudan University, Shanghai, 201102, China. .; Cardiac Center, Children's Hospital of Fudan University, Shanghai, 201102, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 11; Vol. 12 (1), pp. 11765. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
BCG Vaccine*/adverse effects
Granulomatous Disease, Chronic*/complications
Lymphadenopathy*
Tuberculosis, Pulmonary*/diagnostic imaging
Bacillus ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis.
Autorzy:
Qiao J; Department of Orthopedics, The Central Hospital of Wuhan, Wuhan, China; Hubei University of Chinese Medicine,Wuhan, China.
Yang L; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan, China.
Feng J; Department of Orthopedics, Wuhan No.1 Hospital, Wuhan, China.
Dai X; Department of Surgery, Wuhan Pulmonary Hospital, Wuhan, China.
Xu F; Department of Surgery, Wuhan Pulmonary Hospital, Wuhan, China.
Xia P; Department of Orthopedics, The Central Hospital of Wuhan, Wuhan, China. Electronic address: .
Pokaż więcej
Źródło:
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 May; Vol. 118, pp. 264-269. Date of Electronic Publication: 2022 Mar 24.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Linezolid*/adverse effects
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/surgery
Tuberculosis, Spinal*/drug therapy
Tuberculosis, Spinal*/surgery
Humans ; Mycobacterium tuberculosis/drug effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
End-point definition and trial design to advance tuberculosis vaccine development.
Autorzy:
Garcia-Basteiro AL; Centro de Investigação em Sade de Manhiça (CISM), Maputo, Mozambique .; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFECT), Barcelona, Spain.
White RG; London School of Hygiene and Tropical Medicine, London, UK.
Tait D; International AIDS Vaccine Initiative (IAVI) NPC, Cape Town, South Africa.
Schmidt AC; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Rangaka MX; Institute for Global Health and MRC Clinical Trials Unit at University College London, London, UK.; CIDRI-AFRICA, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Quaife M; London School of Hygiene and Tropical Medicine, London, UK.
Nemes E; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Mogg R; Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Hill PC; Centre for International Health, University of Otago, Dunedin, New Zealand.
Harris RC; London School of Hygiene and Tropical Medicine, London, UK.; Sanofi Pasteur, Singapore.
Hanekom WA; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Division of Infection and Immunity, University College London, London, UK.
Frick M; Treatment Action Group, New York, NY, USA.
Fiore-Gartland A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Evans T; Vaccitech, Oxford, UK.
Dagnew AF; Bill and Melinda Gates Medical Research Institute, Cambridge, MA, USA.
Churchyard G; The Aurum Institute, Parktown, South Africa.; Vanderbilt University, Nashville, TN, USA.; University of the Witwatersrand, Johannesburg, South Africa.
Cobelens F; Dept of Global Health and Amsterdam Institute for Global health and development, Amsterdam University Medical Centres, Amsterdam, The Netherlands.
Behr MA; Dept of Medicine, McGill University; McGill International TB Centre, Montreal, QC, Canada.
Hatherill M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Dept of Pathology, University of Cape Town, Cape Town, South Africa.
Pokaż więcej
Źródło:
European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2022 Jun 07; Vol. 31 (164). Date of Electronic Publication: 2022 Jun 07 (Print Publication: 2022).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Clinical Trials as Topic*/methods
Tuberculosis Vaccines*
Vaccine Development*
Adolescent ; Adult ; COVID-19/prevention & control ; Humans ; Mycobacterium tuberculosis ; Research Design ; Tuberculosis/prevention & control
Czasopismo naukowe
Tytuł:
Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis.
Autorzy:
Bomfim CCB; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Fisher L; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Amaral EP; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Mittereder L; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
McCann K; Laboratory of Clinical Immunology and Microbiology - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Correa AAS; Department of Biochemistry and Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.; Graduate Program in Basic and Applied Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
Namasivayam S; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Swamydas M; Laboratory of Clinical Immunology and Microbiology - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Moayeri M; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Weiss JM; Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States.
Chari R; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD, United States.
McVicar DW; Laboratory of Cancer Immunometabolism, Center for Cancer Research, National Cancer Institute, Frederick, MD, United States.
Costa DL; Department of Biochemistry and Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.; Graduate Program in Basic and Applied Immunology - Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
D'Império Lima MR; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Sher A; Laboratory of Parasitic Diseases - National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.
Pokaż więcej
Źródło:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2022 May 02; Vol. 12, pp. 862582. Date of Electronic Publication: 2022 May 02 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural
MeSH Terms:
Hydro-Lyases*/biosynthesis
Hydro-Lyases*/immunology
Macrophages*/immunology
Macrophages*/microbiology
Membrane Proteins*/metabolism
Mycobacterium tuberculosis*/metabolism
Receptor, Interferon alpha-beta*/metabolism
Toll-Like Receptor 2*/metabolism
Adaptor Proteins, Signal Transducing/metabolism ; Animals ; Enzyme Induction ; Mice ; Myeloid Differentiation Factor 88/metabolism ; NF-kappa B/metabolism ; Phagocytosis ; Tuberculosis/metabolism ; Tuberculosis/microbiology
Czasopismo naukowe
Tytuł:
Up-regulated SAMD9L modulated by TLR2 and HIF-1α as a promising biomarker in tuberculosis.
Autorzy:
Zhang XJ; Department of Pathogen Biology, School of Basic Medicine, Weifang Medical University, Weifang, China.; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Xu HS; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Li CH; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Fu YR; Department of Pathogen Biology, School of Basic Medicine, Weifang Medical University, Weifang, China.; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Yi ZJ; School of Medical Laboratory, Key Laboratory of Clinical Laboratory Diagnostics in Universities of Shandong, Weifang Medical University, Weifang, China.
Pokaż więcej
Źródło:
Journal of cellular and molecular medicine [J Cell Mol Med] 2022 May; Vol. 26 (10), pp. 2935-2946. Date of Electronic Publication: 2022 Apr 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hypoxia-Inducible Factor 1, alpha Subunit*/genetics
MicroRNAs*/genetics
Toll-Like Receptor 2*/genetics
Tuberculosis*/diagnosis
Tuberculosis*/genetics
Tumor Suppressor Proteins*/genetics
Biomarkers ; Humans ; Mycobacterium tuberculosis
Czasopismo naukowe
Tytuł:
RNA Expression Analysis of Mycobacterial Methyltransferases Genes in Different Resistant Strains of Mycobacterium tuberculosis.
Autorzy:
Tarashi S; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Zamani MS; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Bahramali G; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.; Viral Vaccine Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fuso A; Department of Experimental Medicine, Sapienza University of Rome, Italy.
Vaziri F; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Karimipoor M; Molecular Medicine Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Fateh A; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Siadat SD; Department of Mycobacteriology and Pulmonary Research, Pasteur Institute of Iran, Tehran, Iran.; Microbiology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Pokaż więcej
Źródło:
Iranian biomedical journal [Iran Biomed J] 2022 May 01; Vol. 26 (3), pp. 240-51. Date of Electronic Publication: 2022 May 01.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Resistance, Bacterial*
Methyltransferases*/genetics
Methyltransferases*/metabolism
Mycobacterium tuberculosis*/enzymology
Mycobacterium tuberculosis*/genetics
Virulence Factors*/genetics
Humans ; Microbial Sensitivity Tests ; Mutation ; RNA, Bacterial/genetics ; Tuberculosis
Czasopismo naukowe
Tytuł:
Opportunities for overcoming tuberculosis: Emerging targets and their inhibitors.
Autorzy:
Yang L; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Hu X; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Chai X; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Ye Q; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Pang J; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Li D; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Hou T; Innovation Institute for Artificial Intelligence in Medicine, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China; State Key Lab of Computer-aided Design and Computer Graphics (CAD&CG), Zhejiang University, Hangzhou, Zhejiang 310058, China. Electronic address: .
Pokaż więcej
Źródło:
Drug discovery today [Drug Discov Today] 2022 Jan; Vol. 27 (1), pp. 326-336. Date of Electronic Publication: 2021 Sep 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/pathogenicity
Tuberculosis*/drug therapy
Tuberculosis*/microbiology
Antitubercular Agents/*pharmacology
Drug Design/*methods
Drug Development/*trends
Drug Evaluation, Preclinical/methods ; Humans ; Latent Tuberculosis/drug therapy ; Tuberculosis, Multidrug-Resistant/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz